• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Fact Sheet

Articles Tagged with ''Fact Sheet''

Fact Sheet

Lavender Essential Oil (CalmAid, Silexan) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Lavender essential oil (Silexan) is a well-tolerated, over-the-counter option for mild to moderate generalized anxiety disorder (GAD), supported by studies showing effect sizes comparable to standard treatments.




Read More
Fact Sheet

Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Gabapentin used to be considered a nonaddictive medication for anxiety and for alcohol dependence, but we now know it may be misused and diverted for its euphoriant effect.




Read More
Fact Sheet

Daridorexant (Quviviq) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Diazepam has a long history of use with good efficacy for anxiety. Its long half-life makes it a particularly effective anxiolytic for some patients, and it is a good alternative to chlordiazepoxide for alcohol withdrawal.




Read More
Fact Sheet

Dexmedetomidine (Igalmi) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Dexmedetomidine is an alpha-2 agonist (think clonidine) that is used at higher doses intravenously (IV) (as Precedex) for ICU sedation.




Read More
Fact Sheet

Clonazepam (Klonopin) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Due to its longer half-life, clonazepam causes fewer breakthrough symptoms compared to alprazolam when used for anxiety. May also work as a good short-term hypnotic, although development of dependence and long half-life limit this use.




Read More
Fact Sheet

Buspirone (BuSpar) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Buspirone is a reasonable option in anxious patients for whom benzodiazepines are not appropriate. Don’t expect as robust a response, and make sure patients know it may take a week or two to kick in.




Read More
Fact Sheet

Insomnia: Medication Management

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

There are many medications available to treat insomnia.




Read More
Fact Sheet

Dementia General Prescribing Tips

August 2, 2025
Rehan Aziz, MD, FAPA
Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information
Older adults undergo substantial changes in drug metabolism and elimination.
Read More
Fact Sheet

Behavioral and Psychological Symptoms of Dementia (BPSD): Medication Treatment

August 2, 2025
Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • Dementia patients often exhibit symptoms like agitation, aggression, wandering, psychosis, depression, and anxiety – collectively referred to as BPSD. 



  • Read More
    Fact Sheet

    Major Neurocognitive Disorder (MND): DSM-5 Differential Diagnosis

    August 2, 2025
    Rehan Aziz, MD

    Dr. Aziz has no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

  • There’s no “cure” for MND, but several medications help mitigate the progression of cognitive and functional decline.



  • Read More
    Previous 1 2 … 20 21 22 23 24 25 26 27 28 … 57 58 Next
    Try The New AskCarlat AI

    Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

    Available In The Carlat Toolkit
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • carlasharp250.jpg
      Psychology and Social Work

      Treating BPD Series, Episode 4: Mentalization-Based Treatment—From Reacting to Reflecting with Carla Sharp, PhD

      Dr. Carla Sharp provides an overview of Mentalization-Based Treatment (MBT) as a treatment for Borderline Personality Disorder.

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.